Gpnmb Is a Potential Marker for the Visceral Pathology in Niemann-Pick Type C Disease-Reference-Cited by-同舟云学术

Gpnmb Is a Potential Marker for the Visceral Pathology in Niemann-Pick Type C Disease

Published:2016-01-15 Issue:1 Volume:11 Page:e0147208
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Marques André R. A.,Gabriel Tanit L.,Aten Jan,van Roomen Cindy P. A. A.,Ottenhoff Roelof,Claessen Nike,Alfonso Pilar,Irún Pilar,Giraldo Pilar,Aerts Johannes M. F. G.,van Eijk Marco

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference52 articles.

1. Niemann-Pick disease type C;MT Vanier;Orphanet J Rare Dis,2010

2. Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis;ED Carstea;Science,1997

3. Niemann-Pick C research from mouse to gene;PG Pentchev;Biochim Biophys Acta,2004

4. Biochemical studies in Niemann-Pick disease. I. Major sphingolipids of liver and spleen;MT Vanier;Biochim Biophys Acta,1983

5. Studies on sphingomyelinase and beta-glucosidase activities in Niemann-Pick disease variants. Phosphodiesterase activities measured with natural and artificial substrates;GT Besley;Biochim Biophys Acta,1983

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glycoprotein non-metastatic melanoma protein B (GPNMB): An attractive target in atherosclerosis;Biochemical and Biophysical Research Communications;2024-11

2. Regional Differences in the Small Intestinal Proteome of Control Mice and of Mice Lacking Lysosomal Acid Lipase;Journal of Proteome Research;2024-02-29

3. Fructose regulates the pentose phosphate pathway and induces an inflammatory and resolution phenotype in Kupffer cells;Scientific Reports;2024-02-18

4. Progranulin and GPNMB: interactions in endo-lysosome function and inflammation in neurodegenerative disease;Journal of Neuroinflammation;2023-11-30

5. Potential Use of the Cholesterol Transfer Inhibitor U18666A as a Potent Research Tool for the Study of Cholesterol Mechanisms in Neurodegenerative Disorders;Molecular Neurobiology;2023-11-23